Cargando…

Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein

Whether the recessive ataxias, Ataxia with oculomotor apraxia type 1 (AOA1) and 2 (AOA2) and Ataxia telangiectasia (AT), can be distinguished by video-oculography and alpha-fetoprotein level remains unknown. We compared 40 patients with AOA1, AOA2 and AT, consecutively referred between 2008 and 2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariani, L. L., Rivaud-Péchoux, S., Charles, P., Ewenczyk, C., Meneret, A., Monga, B. B., Fleury, M.-C., Hainque, E., Maisonobe, T., Degos, B., Echaniz-Laguna, A., Renaud, M., Wirth, T., Grabli, D., Brice, A., Vidailhet, M., Stoppa-Lyonnet, D., Dubois-d’Enghien, C., Le Ber, I., Koenig, M., Roze, E., Tranchant, C., Durr, A., Gaymard, B., Anheim, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681651/
https://www.ncbi.nlm.nih.gov/pubmed/29127364
http://dx.doi.org/10.1038/s41598-017-15127-9
_version_ 1783277950213292032
author Mariani, L. L.
Rivaud-Péchoux, S.
Charles, P.
Ewenczyk, C.
Meneret, A.
Monga, B. B.
Fleury, M.-C.
Hainque, E.
Maisonobe, T.
Degos, B.
Echaniz-Laguna, A.
Renaud, M.
Wirth, T.
Grabli, D.
Brice, A.
Vidailhet, M.
Stoppa-Lyonnet, D.
Dubois-d’Enghien, C.
Le Ber, I.
Koenig, M.
Roze, E.
Tranchant, C.
Durr, A.
Gaymard, B.
Anheim, M.
author_facet Mariani, L. L.
Rivaud-Péchoux, S.
Charles, P.
Ewenczyk, C.
Meneret, A.
Monga, B. B.
Fleury, M.-C.
Hainque, E.
Maisonobe, T.
Degos, B.
Echaniz-Laguna, A.
Renaud, M.
Wirth, T.
Grabli, D.
Brice, A.
Vidailhet, M.
Stoppa-Lyonnet, D.
Dubois-d’Enghien, C.
Le Ber, I.
Koenig, M.
Roze, E.
Tranchant, C.
Durr, A.
Gaymard, B.
Anheim, M.
author_sort Mariani, L. L.
collection PubMed
description Whether the recessive ataxias, Ataxia with oculomotor apraxia type 1 (AOA1) and 2 (AOA2) and Ataxia telangiectasia (AT), can be distinguished by video-oculography and alpha-fetoprotein level remains unknown. We compared 40 patients with AOA1, AOA2 and AT, consecutively referred between 2008 and 2015 with 17 healthy subjects. Video-oculography revealed constant impairments in patients such as cerebellar signs, altered fixation, impaired pursuit, hypometric saccades and abnormal antisaccades. Horizontal saccade latencies could be highly increased reflecting oculomotor apraxia in one third of patients. Specific distinctive alpha-fetoprotein thresholds were determined for AOA1 (7–15 µg/L), AOA2 (15–65 µg/L) and AT (>65 µg/L). Early age onset, severe walking disability, movement disorders, sensori-motor neuropathy and cerebellar atrophy were all shared. In conclusion, alpha-fetoprotein level seems to permit a distinction while video-oculography does not and therefore is not mandatory, even if an appropriate oculomotor examination remains crucial. Our findings are that AOA1, AOA2 and AT form a particular group characterized by ataxia with complex oculomotor disturbances and elevated AFP for which the final diagnosis is relying on genetic analysis. These findings could guide genetic analysis, assist reverse-phenotyping and provide background for the interpretation of the numerous variants of unknown significance provided by next-generation sequencing.
format Online
Article
Text
id pubmed-5681651
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56816512017-11-17 Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein Mariani, L. L. Rivaud-Péchoux, S. Charles, P. Ewenczyk, C. Meneret, A. Monga, B. B. Fleury, M.-C. Hainque, E. Maisonobe, T. Degos, B. Echaniz-Laguna, A. Renaud, M. Wirth, T. Grabli, D. Brice, A. Vidailhet, M. Stoppa-Lyonnet, D. Dubois-d’Enghien, C. Le Ber, I. Koenig, M. Roze, E. Tranchant, C. Durr, A. Gaymard, B. Anheim, M. Sci Rep Article Whether the recessive ataxias, Ataxia with oculomotor apraxia type 1 (AOA1) and 2 (AOA2) and Ataxia telangiectasia (AT), can be distinguished by video-oculography and alpha-fetoprotein level remains unknown. We compared 40 patients with AOA1, AOA2 and AT, consecutively referred between 2008 and 2015 with 17 healthy subjects. Video-oculography revealed constant impairments in patients such as cerebellar signs, altered fixation, impaired pursuit, hypometric saccades and abnormal antisaccades. Horizontal saccade latencies could be highly increased reflecting oculomotor apraxia in one third of patients. Specific distinctive alpha-fetoprotein thresholds were determined for AOA1 (7–15 µg/L), AOA2 (15–65 µg/L) and AT (>65 µg/L). Early age onset, severe walking disability, movement disorders, sensori-motor neuropathy and cerebellar atrophy were all shared. In conclusion, alpha-fetoprotein level seems to permit a distinction while video-oculography does not and therefore is not mandatory, even if an appropriate oculomotor examination remains crucial. Our findings are that AOA1, AOA2 and AT form a particular group characterized by ataxia with complex oculomotor disturbances and elevated AFP for which the final diagnosis is relying on genetic analysis. These findings could guide genetic analysis, assist reverse-phenotyping and provide background for the interpretation of the numerous variants of unknown significance provided by next-generation sequencing. Nature Publishing Group UK 2017-11-10 /pmc/articles/PMC5681651/ /pubmed/29127364 http://dx.doi.org/10.1038/s41598-017-15127-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Mariani, L. L.
Rivaud-Péchoux, S.
Charles, P.
Ewenczyk, C.
Meneret, A.
Monga, B. B.
Fleury, M.-C.
Hainque, E.
Maisonobe, T.
Degos, B.
Echaniz-Laguna, A.
Renaud, M.
Wirth, T.
Grabli, D.
Brice, A.
Vidailhet, M.
Stoppa-Lyonnet, D.
Dubois-d’Enghien, C.
Le Ber, I.
Koenig, M.
Roze, E.
Tranchant, C.
Durr, A.
Gaymard, B.
Anheim, M.
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein
title Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein
title_full Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein
title_fullStr Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein
title_full_unstemmed Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein
title_short Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein
title_sort comparing ataxias with oculomotor apraxia: a multimodal study of aoa1, aoa2 and at focusing on video-oculography and alpha-fetoprotein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681651/
https://www.ncbi.nlm.nih.gov/pubmed/29127364
http://dx.doi.org/10.1038/s41598-017-15127-9
work_keys_str_mv AT marianill comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT rivaudpechouxs comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT charlesp comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT ewenczykc comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT menereta comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT mongabb comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT fleurymc comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT hainquee comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT maisonobet comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT degosb comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT echanizlagunaa comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT renaudm comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT wirtht comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT grablid comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT bricea comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT vidailhetm comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT stoppalyonnetd comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT duboisdenghienc comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT leberi comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT koenigm comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT rozee comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT tranchantc comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT durra comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT gaymardb comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein
AT anheimm comparingataxiaswithoculomotorapraxiaamultimodalstudyofaoa1aoa2andatfocusingonvideooculographyandalphafetoprotein